Renal Allograft Recipients with High Susceptibility to Cutaneous Malignancy Have an Increased Prevalence of Human Papillomavirus DNA in Skin Tumours and a Greater Risk of Anogenital Malignancy

Overview

Journal Br J Cancer

Specialty Oncology

Date 1997 Jan 1

PMID 9043031

Citations 16

Authors

M J Arends

E C Benton

K M McLaren

L A Stark

J A Hunter

C C Bird

Affiliations

Soon will be listed here.

Abstract

Renal allograft recipients (RARs) have a well-documented increased incidence of viral warts and cutaneous neoplasia, particularly those with long graft life and high sun exposure. A clinicopathological survey of 69 RARs in south-east Scotland, with follow-up periods of up to 28 years after transplantation, revealed marked variation in patient susceptibility to cutaneous malignancy with concomitant variation in HPV prevalence. Skin cancers were found in 34 patients. Eight patients showed high susceptibility [defined as more than four intraepidermal carcinomas (IECs) or invasive squamous cell carcinomas (SCCs)] 42 had intermediate susceptibility (1-3 IECs or SCCs, or >3 keratoses) and 18 had low susceptibility (< or = 3 keratoses and no cancers). SCCs, IECs and keratoses from the high-susceptibility group were found to have greater prevalences of human papillomavirus (HPV) DNA (56%, 45% and 50% respectively), than SCCs (0%) and IECs (33%) from intermediate-susceptibility RARs and keratoses (36%) from the combined intermediate- and low-susceptibility groups and compared with a group of immunocompetent controls (27%, 20% and 15% respectively). No differences in p53 protein accumulation, determined immunohistochemically, were observed in tumours from the three groups. Categorization of RARs by susceptibility to cutaneous malignancy provides clinically useful information, as significantly more high-susceptibility patients (38%) developed aggressive, potentially lethal anogenital or cutaneous squamous cell cancers than did patients in the intermediate group (5%, P=0.005) or the low-susceptibility group (0%).

Citing Articles

Screening of Anal HPV Precancerous Lesions: A Review after Last Recommendations.

Natale A, Brunetti T, Orioni G, Gaspari V J Clin Med. 2024; 13(17).

PMID: 39274459 PMC: 11395998. DOI: 10.3390/jcm13175246.

Pediatric Onco-Nephrology: Time to Spread the Word-Part II: Long-Term Kidney Outcomes in Survivors of Childhood Malignancy and Malignancy after Kidney Transplant.

Nada A, Jetton J Pediatr Nephrol. 2021; 37(6):1285-1300.

PMID: 34490519 DOI: 10.1007/s00467-021-05172-y.

The transplant cohort of the German center for infection research (DZIF Tx-Cohort): study design and baseline characteristics.

Karch A, Schindler D, Kuhn-Steven A, Blaser R, Kuhn K, Sandmann L Eur J Epidemiol. 2021; 36(2):233-241.

PMID: 33492549 PMC: 7987595. DOI: 10.1007/s10654-020-00715-3.

Giant anal condyloma (giant condyloma acuminatum of anus) after allogeneic bone marrow transplantation associated with human papillomavirus: a case report.

Hyun J, Kim G, Choi B, Kim M, Park S J Med Case Rep. 2015; 9:9.

PMID: 25597932 PMC: 4334849. DOI: 10.1186/1752-1947-9-9.

Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis.

Wang J, Aldabagh B, Yu J, Arron S J Am Acad Dermatol. 2014; 70(4):621-629.

PMID: 24629358 PMC: 3959664. DOI: 10.1016/j.jaad.2014.01.857.

References

Van der Leest R, Zachow K, Ostrow R, Bender M, PASS F, Faras A . Human papillomavirus heterogeneity in 36 renal transplant recipients. Arch Dermatol. 1987; 123(3):354-7. DOI: 10.1001/archderm.123.3.354. View

Bavinck J, Gissmann L, Claas F, van der Woude F, Persijn G, Ter Schegget J . Relation between skin cancer, humoral responses to human papillomaviruses, and HLA class II molecules in renal transplant recipients. J Immunol. 1993; 151(3):1579-86. View

Alloub M, Barr B, McLaren K, Smith I, Bunney M, Smart G . Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. BMJ. 1989; 298(6667):153-6. PMC: 1835493. DOI: 10.1136/bmj.298.6667.153. View

Ellis J, Keating P, Baird J, Hounsell E, Renouf D, Rowe M . The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med. 1995; 1(5):464-70. DOI: 10.1038/nm0595-464. View

Shamanin V, zur Hausen H, Lavergne D, Proby C, Leigh I, Neumann C . Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst. 1996; 88(12):802-11. DOI: 10.1093/jnci/88.12.802. View

Arends M, Wyllie A, Bird C . Human papillomavirus type 18 is associated with less apoptosis in fibroblast tumours than human papillomavirus type 16. Br J Cancer. 1995; 72(3):646-9. PMC: 2033887. DOI: 10.1038/bjc.1995.388. View

LUTZNER M, CROISSANT O, Ducasse M, Kreis H, CROSNIER J, Orth G . A potentially oncogenic human papillomavirus (HPV-5) found in two renal allograft recipients. J Invest Dermatol. 1980; 75(4):353-6. DOI: 10.1111/1523-1747.ep12531131. View

zur Hausen H . Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events?. Lancet. 1982; 2(8312):1370-2. DOI: 10.1016/s0140-6736(82)91273-9. View

LUTZNER M, Orth G, Dutronquay V, Ducasse M, Kreis H, CROSNIER J . Detection of human papillomavirus type 5 DNA in skin cancers of an immunosuppressed renal allograft recipient. Lancet. 1983; 2(8347):422-4. DOI: 10.1016/s0140-6736(83)90389-6. View

10.

Banks L, Matlashewski G, Crawford L . Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem. 1986; 159(3):529-34. DOI: 10.1111/j.1432-1033.1986.tb09919.x. View

11.

Blessing K, McLaren K, Benton E, Barr B, Bunney M, Smith I . Histopathology of skin lesions in renal allograft recipients--an assessment of viral features and dysplasia. Histopathology. 1989; 14(2):129-39. DOI: 10.1111/j.1365-2559.1989.tb02123.x. View

12.

Rudlinger R, GROB R . Papillomavirus infection and skin cancer in renal allograft recipients. Lancet. 1989; 1(8647):1132-3. DOI: 10.1016/s0140-6736(89)92403-3. View

13.

Muller M, Kelly G, Fiedler M, Gissmann L . Human papillomavirus type 48. J Virol. 1989; 63(11):4907-8. PMC: 251133. DOI: 10.1128/JVI.63.11.4907-4908.1989. View

14.

Blessing K, McLaren K, Morris R, Barr B, Benton E, Alloub M . Detection of human papillomavirus in skin and genital lesions of renal allograft recipients by in situ hybridization. Histopathology. 1990; 16(2):181-5. DOI: 10.1111/j.1365-2559.1990.tb01087.x. View

15.

Arends M, Wyllie A, Bird C . Papillomaviruses and human cancer. Hum Pathol. 1990; 21(7):686-98. DOI: 10.1016/0046-8177(90)90027-3. View

16.

Yoshikawa T, Rae V, Bruins-Slot W, van den Berg J, Taylor J, Streilein J . Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol. 1990; 95(5):530-6. DOI: 10.1111/1523-1747.ep12504877. View

17.

Eliezri Y, Silverstein S, Nuovo G . Occurrence of human papillomavirus type 16 DNA in cutaneous squamous and basal cell neoplasms. J Am Acad Dermatol. 1990; 23(5 Pt 1):836-42. DOI: 10.1016/0190-9622(90)70299-w. View

18.

Smith S, Davis I, Leshin B, Fleischer Jr A, White W, Feldman S . Absence of human papillomavirus in squamous cell carcinomas of nongenital skin from immunocompromised renal transplant patients. Arch Dermatol. 1993; 129(12):1585-8. View

19.

zur Hausen H . Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix. Lancet. 1994; 343(8903):955-7. DOI: 10.1016/s0140-6736(94)90070-1. View

20.

Ogunbiyi O, Scholefield J, Raftery A, Smith J, Duffy S, Sharp F . Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg. 1994; 81(3):365-7. DOI: 10.1002/bjs.1800810313. View